SCHEMBL27615982

SCHEMBL27615982

O=C(O)Nc1ccc(C(F)(F)F)cc1NC(=O)CC(=O)c1cccc(-c2ccc(C3CC3)nc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
KMT2A Q03164 1/20 0.46
KCNH2 Q12809 4/20 0.42
CCR2 P41597 3/20 0.42
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
SYK P43405 2/20 0.39
CCR6 P51684 1/20 0.38
GRIN1 Q05586 4/20 0.38
GRIN2B Q13224 4/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
KDM4E B2RXH2 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
RIPK1 Q13546 1/20 0.36
POLB P06746 1/20 0.36
IDO1 P14902 1/20 0.36
F2R P25116 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27615833 0.89 ALDH1A1 (0.46) MEN1ALDH1A1KMT2AKCNH2CCR2
SCHEMBL5556798 0.89 MEN1 (0.40) MEN1ALDH1A1KMT2AKCNH2CCR2
SCHEMBL27597180 0.87 ABL1 (0.42)
SCHEMBL27597157 0.87 MEN1 (0.43) MEN1ALDH1A1KMT2AKCNH2CCR2
SCHEMBL27597128 0.87 ALDH1A1 (0.50) MEN1ALDH1A1KMT2ASLC1A3SLC1A2
SCHEMBL28754186 0.87 POLB (0.40) KCNH2CCR2POLBIDO1
SCHEMBL27615925 0.86 POLB (0.39) KCNH2CCR2SYKPOLBIDO1
SCHEMBL27615928 0.85 ALDH1A1 (0.45) MEN1ALDH1A1KMT2AKCNH2CCR2
SCHEMBL27615852 0.85 MEN1 (0.48) MEN1ALDH1A1KMT2ASLC1A3SLC1A2
SCHEMBL27597107 0.83 MEN1 (0.46) MEN1ALDH1A1KMT2ASLC1A3SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497333-C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2009-06-10 CN disclosed
CN-1633430-A Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders HOFFMANN LA ROCHE (CH) 2005-06-29 CN disclosed